(Q39449387)

English

Valsartan, independently of AT1 receptor or PPARγ, suppresses LPS-induced macrophage activation and improves insulin resistance in cocultured adipocytes

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Valsartan, independently of AT1 receptor or PPARγ, suppresses LPS-induced macrophage activation and improves insulin resistance in cocultured adipocytes (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

0 references

1 reference

based on heuristic

inferred from title

insulin resistance

1 reference

based on heuristic

inferred from title

Akifumi Kushiyama

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

13

object named as

Issei Komuro

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Midori Fujishiro

4

object named as

Midori Fujishiro

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Hiroki Kurihara

11

object named as

Hiroki Kurihara

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Hideyuki Sakoda

2

object named as

Hideyuki Sakoda

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Hiroshi Akazawa

12

object named as

Hiroshi Akazawa

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

author name string

Misaki Iwashita

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Haruya Ohno

5

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Yusuke Nakatsu

6

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Toshiaki Fukushima

7

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sonoko Kumamoto

8

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Yoshihiro Tsuchiya

9

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Takako Kikuchi

10

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Hideaki Kamata

14

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Fusanori Nishimura

15

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Tomoichiro Asano

16

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

publication date

1 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

American Journal of Physiology - Endocrinology and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

302

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

E286-96

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Early B-cell factor (O/E-1) is a promoter of adipogenesis and involved in control of genes important for terminal adipocyte differentiation.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00324.2011

21 January 2018

The C type natriuretic peptide receptor tethers AHNAK1 at the plasma membrane to potentiate arachidonic acid-induced calcium mobilization

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00324.2011

21 January 2018

Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00324.2011

21 January 2018

Expression of specific mRNAs during adipose differentiation: identification of an mRNA encoding a homologue of myelin P2 protein

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00324.2011

21 January 2018

Vascular inflammation and the renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00324.2011

21 January 2018

Metabolic endotoxemia initiates obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00324.2011

21 January 2018

Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00324.2011

21 January 2018

Gamma-linolenic acid inhibits inflammatory responses by regulating NF-kappaB and AP-1 activation in lipopolysaccharide-induced RAW 264.7 macrophages

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00324.2011

21 January 2018

Telmisartan and irbesartan therapy in type 2 diabetic patients treated with rosiglitazone: effects on insulin-resistance, leptin and tumor necrosis factor-alpha.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00324.2011

21 January 2018

Abdominal obesity and metabolic syndrome

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00324.2011

21 January 2018

Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00324.2011

21 January 2018

Effect of ramipril on the incidence of diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00324.2011

21 January 2018

Molecular activation of PPARgamma by angiotensin II type 1-receptor antagonists

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00324.2011

21 January 2018

Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00324.2011

21 January 2018

Inflammation and metabolic disorders

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00324.2011

21 January 2018

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00324.2011

21 January 2018

Pioglitazone ameliorates tumor necrosis factor-alpha-induced insulin resistance by a mechanism independent of adipogenic activity of peroxisome proliferator--activated receptor-gamma

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00324.2011

21 January 2018

Mechanisms linking obesity to insulin resistance and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00324.2011

21 January 2018

ONTARGET, TRANSCEND, and PRoFESS: new-onset diabetes, atrial fibrillation, and left ventricular hypertrophy.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00324.2011

21 January 2018

New treatment strategies for patients with hypertension and insulin resistance

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00324.2011

21 January 2018

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00324.2011

21 January 2018

Microbial ecology: human gut microbes associated with obesity

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00324.2011

21 January 2018

PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00324.2011

21 January 2018

Effect of valsartan on the incidence of diabetes and cardiovascular events

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00324.2011

21 January 2018

Macrophages, inflammation, and insulin resistance

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00324.2011

21 January 2018

C-reactive protein (CRP)-lowering agents

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00324.2011

21 January 2018

The insulin resistance syndrome: definition and dietary approaches to treatment

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00324.2011

21 January 2018

Insulin-regulated sorting of glucose transporters in 3T3-L1 adipocytes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00324.2011

21 January 2018

Translocation of the glucose transporter (GLUT4) to the cell surface in permeabilized 3T3-L1 adipocytes: effects of ATP insulin, and GTP gamma S and localization of GLUT4 to clathrin lattices

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00324.2011

21 January 2018

The role of adipose cell size and adipose tissue insulin sensitivity in the carbohydrate intolerance of human obesity

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00324.2011

21 January 2018

Adipose tissue: from lipid storage compartment to endocrine organ

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00324.2011

21 January 2018

Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00324.2011

21 January 2018

Thiazolidinedione use and bone loss in older diabetic adults

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00324.2011

21 January 2018

Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00324.2011

21 January 2018

Relationship between adipocyte size and adipokine expression and secretion

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00324.2011

21 January 2018

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00324.2011

21 January 2018

Telmisartan but not valsartan increases caloric expenditure and protects against weight gain and hepatic steatosis

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00324.2011

21 January 2018

Obesity is associated with macrophage accumulation in adipose tissue

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00324.2011

21 January 2018

Basal lipolysis, not the degree of insulin resistance, differentiates large from small isolated adipocytes in high-fat fed mice.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00324.2011

21 January 2018

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00324.2011

21 January 2018

Macrophage-adipocyte interaction: marked interleukin-6 production by lipopolysaccharide.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00324.2011

21 January 2018

Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00324.2011

21 January 2018

Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00324.2011

21 January 2018

Identifiers

10.1152/AJPENDO.00324.2011

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39449387&oldid=2118300796"